Introduction/Overview
Juglone (5-hydroxy-1,4-naphthoquinone, CAS number: 481-39-0) is a natural naphthoquinone compound mainly found in Juglans regia plants, particularly in the leaves, shells, and roots of walnut trees. As a yellow dye, juglone not only has practical value in the traditional dyeing industry, but also has become a hot topic in natural product pharmacology research due to its significant biological activity. In recent years, with the in-depth exploration of its antibacterial, anti-tumor, and apoptosis regulating effects, juglone has shown great potential for application in tumor treatment, especially in the field of lung cancer.
As one of the malignant tumors with the highest incidence rate and mortality in the world, lung cancer urgently needs to develop new effective and low toxic therapeutic drugs. Walnut quinone exhibits excellent anti lung cancer activity by regulating tumor cell growth and apoptosis through multiple targets and pathways. This article will provide a systematic review of the chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activity and mechanism of action, drug evaluation and pharmacokinetic characteristics of juglone, with a focus on exploring its molecular targets and clinical application prospects in the treatment of lung cancer. The aim is to provide a theoretical basis and research direction for the drug development of juglone.
Chemical structure and physicochemical properties
The chemical name of walnut quinone is 5-hydroxy-1,4-naphthoquinone, with a molecular formula of C10H6O3 and a molecular weight of 174.1550. The core of its structure is a 1,4-naphthoquinone skeleton, and the introduction of a 5-hydroxy group endows it with unique electronic properties and biological activity. The LogP value of juglone is 1.7708, indicating that it has moderate lipid solubility, which is beneficial for cell membrane penetration. The polar surface area (TPSA) is 54.37 Å ², indicating its good absorption and distribution potential in living organisms. The water solubility index is 0.5483, indicating low water solubility but good solubility in organic solvents.
Walnut quinone has a high blood-brain barrier permeability, suggesting that it may affect central nervous system function or be used in research on neurological related diseases. Importantly, juglone did not exhibit hERG channel inhibitory activity, reducing its risk of cardiac toxicity. The Ames test result is 1.5, indicating low genotoxicity and ideal safety.
Plant sources and extraction methods
Hutao quinone mainly comes from Juglans regia and its related species. The leaves, shells, roots, and bark of walnut trees all contain varying amounts of juglone, with the shell and roots having the highest content. Traditionally, walnut shells have been used to extract natural dyes, while modern research focuses more on the extraction and purification of their pharmacological active ingredients.
The extraction of juglone is usually carried out using organic solvent extraction method. Common solvents include ethanol, methanol, ethyl acetate, and their mixed solvent systems. The extraction process generally includes crushing plant materials, solvent soaking, ultrasound assisted extraction or reflux extraction, followed by purification through liquid-liquid distribution, column chromatography and other methods. High performance liquid chromatography (HPLC) and mass spectrometry (MS) techniques are widely used for qualitative and quantitative analysis of juglone.
In recent years, supercritical CO2 extraction and microwave-assisted extraction techniques have also been introduced into the research of walnut quinone extraction to improve extraction efficiency and purity, reduce solvent usage, and comply with green chemistry principles.
Pharmacological activity research
Antibacterial activity
Momoquinone exhibits broad-spectrum antibacterial activity and can inhibit the growth of various Gram positive and Gram negative bacteria. Research has shown that walnut quinone has significant inhibitory effects on common pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Its antibacterial mechanism mainly involves cell membrane damage, oxidative stress induction, and energy metabolism interference.
In addition, juglone is also effective against certain drug-resistant strains, demonstrating its potential application value in antimicrobial resistance issues.
Antitumor activity
The anti-tumor activity of walnut quinone is the focus of its research. Both in vitro cell experiments and in vivo animal models have confirmed that juglone can significantly inhibit the proliferation of various tumor cells and induce cell apoptosis. Especially in lung cancer cell lines, juglone exhibits strong cytotoxicity and anti migratory ability.
Walnut quinone regulates multiple signaling pathways, affects cell cycle progression and the expression of apoptosis related proteins, and inhibits the growth and metastasis of tumor cells. In addition, walnut quinone also has anti angiogenic effects and blocks the nutritional supply to tumors.
Other pharmacological effects
Walnut quinone has also been reported to have various biological activities such as antioxidant, anti-inflammatory, and neuroprotective properties. Its anti-inflammatory effect is mainly achieved by inhibiting the release of inflammatory mediators and regulating signaling pathways. The neuroprotective effect is related to its antioxidant capacity and regulation of cell apoptosis.
Mechanism of action and molecular targets
The mechanism by which juglone induces cell apoptosis is mainly achieved through the mitochondrial pathway. Its function involves multiple molecular targets and signaling pathways, and has been widely studied in the treatment of lung cancer.
Mitochondrial pathway induces cell apoptosis
Walnut quinone can disrupt mitochondrial membrane potential, promote cytochrome c release, activate caspase cascade reaction, and ultimately lead to cell apoptosis. It regulates the expression of BCL2 family proteins, reduces the level of anti apoptotic protein BCL2, promotes the activity of pro apoptotic proteins, and enhances cell apoptosis signals.
Key molecular targets
- BCL2 Walnut quinone reduces BCL2 expression, relieves inhibition of cell apoptosis, and promotes the process of apoptosis.
- ABCA1 Walnut quinone is involved in intracellular cholesterol transport, and its regulation of ABCA1 may affect cell membrane fluidity and signal transduction.
- TLR4 As an immune regulatory receptor, juglone's regulation of TLR4 affects inflammatory response and tumor microenvironment.
- STAT3 Walnut quinone inhibits the STAT3 signaling pathway, blocking tumor cell proliferation and immune escape.
- ESR2 (estrogen receptor beta)The regulation of ESR2 by juglone may affect hormone dependent growth of tumor cells.
- MAPT (microtubule associated protein Tau)Regulating the stability of the cytoskeleton, walnut quinone may interfere with tumor cell migration by affecting MAPT.
- MMP2 Inhibit matrix metalloproteinase MMP2, block tumor cell invasion and metastasis.
- PIK3CG Walnut quinone participates in the PI3K/Akt signaling pathway and inhibits PIK3CG activity, cell proliferation, and survival.
- RELA (NF - κ B p65 subunit)Walnut quinone inhibits NF - κ B signaling, weakens inflammation and tumor promoting effects.
- MAPK1 Regulating cell proliferation and differentiation, juglone regulates cell fate through MAPK1.
In summary, walnut quinone exerts its anti-tumor and antibacterial effects through multi-target and multi pathway synergistic effects, demonstrating a complex and precise pharmacological mechanism.
Evaluation of drug properties and pharmacokinetics
The pharmacological parameters of juglone indicate that it has good potential for drug development. Moderate molecular weight and LogP value are beneficial for the in vivo absorption and distribution of drugs. The lower polar surface area and water solubility index suggest potential solubility limitations during oral administration, but can be overcome through formulation optimization.
Walnut quinone has high blood-brain barrier permeability, indicating its potential value in the treatment of central nervous system diseases. HERG channel inhibition is negative and has a lower risk of genotoxicity, providing assurance for its safety.
In terms of pharmacokinetics, existing studies have shown that juglone is rapidly absorbed orally and widely distributed in the body, but further systematic research is needed on its metabolic pathways and half-life. Its main metabolism may involve phenolic hydroxylation and reduction reactions in the liver, and the activity and toxicity assessment of metabolites will also be a focus of future research.
Clinical application prospects and prospects
As a natural product, hydroquinone has shown potential as an adjuvant therapy for lung cancer and other malignant tumors due to its multi-target anti-tumor activity and good drug properties. By combining modern drug design with nanocarrier technology, it is expected to overcome the limitations of water solubility and bioavailability, and achieve clinical translation.
Future research should focus on:
- Pharmacokinetic and toxicological evaluation of the system Clarify its metabolic pathway and safe dosage range within the body.
- Structural modification and derivative development Enhance activity and selectivity, optimize pharmacokinetic properties.
- Combination therapy strategy Explore the synergistic effects of juglone with existing chemotherapy drugs or immunotherapy.
- Preclinical animal models and early clinical trials Verify its therapeutic effect and safety.
- In depth study of mechanisms Reveal its impact on the tumor microenvironment and immune regulation, and expand the scope of indications.
In addition, the antibacterial and anti-inflammatory properties of juglone also provide a possibility for its application in infectious diseases and inflammation related diseases.
Conclusion
As a widely sourced, structurally simple, and biologically active natural naphthoquinone compound, HuTao quinone has become an important research object in the field of natural product pharmacology due to its unique antibacterial and anti-tumor effects, especially in the multi-target regulatory mechanism of lung cancer treatment. Its good pharmacological parameters and safety foundation have laid a solid foundation for subsequent drug development. In the future, by combining modern medicinal chemistry and biotechnology methods, juglone is expected to move from the laboratory to clinical practice and become a new model for the development of natural anti-cancer drugs.